155 related articles for article (PubMed ID: 33640630)
21. Synthesis and anticancer activity of some novel 2-phenazinamine derivatives.
Gao X; Lu Y; Fang L; Fang X; Xing Y; Gou S; Xi T
Eur J Med Chem; 2013 Nov; 69():1-9. PubMed ID: 23995213
[TBL] [Abstract][Full Text] [Related]
22. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents.
Sabbah DA; Hishmah B; Sweidan K; Bardaweel S; AlDamen M; Zhong HA; Abu Khalaf R; Hasan Ibrahim A; Al-Qirim T; Abu Sheikha G; Mubarak MS
Anticancer Agents Med Chem; 2018; 18(2):263-276. PubMed ID: 28901259
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy.
Qian J; Xu Z; Meng C; Liu J; Hsu PL; Li Y; Zhu W; Yang Y; Morris-Natschke SL; Lee KH; Zhang Y; Ling Y
Eur J Med Chem; 2020 Oct; 204():112610. PubMed ID: 32736231
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, antitumor activity, and structure-activity relationship of some benzo[a]pyrano[2,3-c]phenazine derivatives.
Gao J; Chen M; Tong X; Zhu H; Yan H; Liu D; Li W; Qi S; Xiao D; Wang Y; Lu Y; Jiang F
Comb Chem High Throughput Screen; 2015; 18(10):960-74. PubMed ID: 26369405
[TBL] [Abstract][Full Text] [Related]
25. Novel synthetic isoquinolino[5,4-ab]phenazines: inhibition toward topoisomerase I, antitumor and DNA photo-cleaving activities.
Yang P; Yang Q; Qian X; Cui J
Bioorg Med Chem; 2005 Nov; 13(21):5909-14. PubMed ID: 16115776
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of homoerythrina alkaloid derivatives bearing a triazole moiety as PARP-1 inhibitors and as potential antitumor drugs.
Li S; Li XY; Zhang TJ; Kamara MO; Liang JW; Zhu J; Meng FH
Bioorg Chem; 2020 Jan; 94():103385. PubMed ID: 31669094
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido)benzoyl hydrazide derivatives as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
Li XY; Liang JW; Mohamed O K; Zhang TJ; Lu GQ; Meng FH
Eur J Med Chem; 2018 Jun; 154():267-279. PubMed ID: 29807332
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.
Duan YC; Jin LF; Ren HM; Zhang SJ; Liu YJ; Xu YT; He ZH; Song Y; Yuan H; Chen SH; Guan YY
Eur J Med Chem; 2021 Aug; 220():113453. PubMed ID: 33957387
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay.
Prast-Nielsen S; Dexheimer TS; Schultz L; Stafford WC; Cheng Q; Xu J; Jadhav A; Arnér ES; Simeonov A
Free Radic Biol Med; 2011 May; 50(9):1114-23. PubMed ID: 21262347
[TBL] [Abstract][Full Text] [Related]
30. A thioredoxin reductase 1 inhibitor pyrano [3,2-a] phenazine inhibits A549 cells proliferation and migration through the induction of reactive oxygen species production.
Ding Q; Wang H; Wang Y; Lu Y
Mol Biol Rep; 2022 Sep; 49(9):8835-8845. PubMed ID: 35780225
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
Kim JS; Rhee HK; Park HJ; Lee IK; Lee SK; Suh ME; Lee HJ; Ryu CK; Choo HY
Bioorg Med Chem; 2007 Jan; 15(1):451-7. PubMed ID: 17035025
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of novel methylenecyclohexenone derivatives as TrxR inhibitors in suppressing the proliferation and metastasis of human cancer cells.
Meng C; Qian J; Xu Z; Liu J; Shan W; Zhu P; Zhu W; Miao J; Ling CC; Ling Y
Bioorg Chem; 2020 Dec; 105():104360. PubMed ID: 33074118
[TBL] [Abstract][Full Text] [Related]
33. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells.
Chen X; Chen X; Zhang X; Wang L; Cao P; Rajamanickam V; Wu C; Zhou H; Cai Y; Liang G; Wang Y
Redox Biol; 2019 Feb; 21():101061. PubMed ID: 30590310
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of Pontin ATPase inhibitors through a molecular docking approach.
Elkaim J; Lamblin M; Laguerre M; Rosenbaum J; Lestienne P; Eloy L; Cresteil T; Felpin FX; Dessolin J
Bioorg Med Chem Lett; 2014 Jun; 24(11):2512-6. PubMed ID: 24767849
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety.
Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM
Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946
[TBL] [Abstract][Full Text] [Related]
36. Identification of Phenazine-Based MEMO1 Small-Molecule Inhibitors: Virtual Screening, Fluorescence Polarization Validation, and Inhibition of Breast Cancer Migration.
Labrecque CL; Hilton CN; Airas J; Blake A; Rubenstein KJ; Parish CA; Pollock JA
ChemMedChem; 2021 Apr; 16(7):1163-1171. PubMed ID: 33332774
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationships for pyrido-, imidazo-, pyrazolo-, pyrazino-, and pyrrolophenazinecarboxamides as topoisomerase-targeted anticancer agents.
Gamage SA; Spicer JA; Rewcastle GW; Milton J; Sohal S; Dangerfield W; Mistry P; Vicker N; Charlton PA; Denny WA
J Med Chem; 2002 Jan; 45(3):740-3. PubMed ID: 11806725
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
40. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
